Here, we evaluated the levels of 95 DUBs by using bioinformatics analysis and found that YOD1 expression was dramatically diminished in HNSCC, and the low level of YOD1 correlated positively with lymph node metastasis and poor prognosis of HNSCC patients in our cohort. This evidence concerns the gene YOD1 and head and neck squamous cell carcinoma.